The global Computer Vision in Healthcare Market is experiencing rapid growth, driven by advancements in medical imaging, research, surgical assistance, and early disease detection technologies. Leveraging AI and machine learning, computer vision (CV) enhances diagnostic accuracy and efficiency, particularly in areas like tumor detection, cancer detection, and early disease recognition. Integrating CV with healthcare systems has significantly improved patient outcomes by enabling more precise diagnostics and treatment plans. In 2022, approximately 20 million new cancer cases were recorded globally, with 9.7 million deaths attributed to the disease. The most prevalent cancers included lung, breast, colorectal, prostate, stomach, liver, and cervical cancers. By 2040, the annual incidence of new cancer cases is projected to rise to 29.9 million.